In conclusion, the results of our study reveal that glomerulopathy in DD1 patients might be a direct consequence of ClC-5 impairment in podocytes, and that Dent disease type 1 should be considered not only as a tubulopathy, but also as a podocytopathy. The gene discussed is CLCN5; the disease is lipoprotein glomerulopathy.